FDA Inspection 882856 — Shore Institute For Reproductive Medicine, P.C.
The FDA completed an inspection of Shore Institute For Reproductive Medicine, P.C. on June 11, 2014 in Lakewood, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 11, 2014
- Fiscal Year
- 2014
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Lakewood, NJ (United States)